Role of FXR in Renal Physiology and Kidney Diseases
International Journal of Molecular Sciences · 26.01.2023 · 24 (3) · 2408
DOI: 10.3390/ijms24032408 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 26.01.2023. Verfasst von Yanlin Guo und 2 weiteren Autor:innen. Beteiligte Einrichtung: Health Science Center, East China Normal University, Shanghai 200241, China. Hauptthemen laut MEDLINE: Diabetic Nephropathies, Kidney. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 131 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, the National Key R&D Program of China, the East China Normal University Medicine and Health Joint Fund.
Abstract (Originalsprache)
Farnesoid X receptor, also known as the bile acid receptor, belongs to the nuclear receptor (NR) superfamily of ligand-regulated transcription factors, which performs its functions by regulating the transcription of target genes. FXR is highly expressed in the liver, small intestine, kidney and adrenal gland, maintaining homeostasis of bile acid, glucose and lipids by regulating a diverse array of target genes. It also participates in several pathophysiological processes, such as inflammation, immune responses and fibrosis. The kidney is a key organ that manages water and solute homeostasis for the whole body, and kidney injury or dysfunction is associated with high morbidity and mortality. In the kidney, FXR plays an important role in renal water reabsorption and is thought to perform protective functions in acute kidney disease and chronic kidney disease, especially diabetic kidney disease. In this review, we summarize the recent advances in the understanding of the physiological and pathophysiological function of FXR in the kidney.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Health Science Center, East China Normal University, Shanghai 200241, China.
ORCID-Profile: Yanlin Guo, Xiaoyan Zhang
Förderung
- National Natural Science Foundation of China
- the National Key R&D Program of China
- the East China Normal University Medicine and Health Joint Fund
- National Key R&D Program of China
- East China Normal University Medicine and Health Joint Fund
Zitieren
APA
Guo, Y., Xie, G., & Zhang, X. (2023). Role of FXR in Renal Physiology and Kidney Diseases. International Journal of Molecular Sciences, 24(3), 2408. https://doi.org/10.3390/ijms24032408
Vancouver
Guo Y, Xie G, Zhang X. Role of FXR in Renal Physiology and Kidney Diseases. International Journal of Molecular Sciences. 2023;24(3):2408. doi:10.3390/ijms24032408
BibTeX
@article{Guo2023,
author = {Guo, Yanlin and Xie, Guixiang and Zhang, Xiaoyan},
title = {Role of FXR in Renal Physiology and Kidney Diseases},
journal = {International Journal of Molecular Sciences},
year = {2023},
volume = {24},
number = {3},
pages = {2408},
doi = {10.3390/ijms24032408}
}
EUVIMED